BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31513968)

  • 1. Verbal memory predicts treatment outcome in syndromal anxious depression: An iSPOT-D report.
    Braund TA; Tillman G; Palmer DM; Harris AWF
    J Affect Disord; 2020 Jan; 260():245-253. PubMed ID: 31513968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterising anxiety in major depressive disorder and its use in predicting antidepressant treatment outcome: An iSPOT-D report.
    Braund TA; Palmer DM; Williams LM; Harris AW
    Aust N Z J Psychiatry; 2019 Aug; 53(8):782-793. PubMed ID: 30880405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxious distress predicts subsequent treatment outcome and side effects in depressed patients starting antidepressant treatment.
    Gaspersz R; Lamers F; Kent JM; Beekman ATF; Smit JH; van Hemert AM; Schoevers RA; Penninx BWJH
    J Psychiatr Res; 2017 Jan; 84():41-48. PubMed ID: 27693981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimensions of anxiety in Major depressive disorder and their use in predicting antidepressant treatment outcome: an iSPOT-D report.
    Braund TA; Palmer DM; Williams LM; Harris AWF
    Psychol Med; 2020 Apr; 50(6):1032-1042. PubMed ID: 31023398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinically useful self-report measure of the DSM-5 anxious distress specifier for major depressive disorder.
    Zimmerman M; Chelminski I; Young D; Dalrymple K; Walsh E; Rosenstein L
    J Clin Psychiatry; 2014 Jun; 75(6):601-7. PubMed ID: 24813209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brexpiprazole as adjunctive treatment of major depressive disorder with anxious distress: Results from a post-hoc analysis of two randomised controlled trials.
    McIntyre RS; Weiller E; Zhang P; Weiss C
    J Affect Disord; 2016 Sep; 201():116-23. PubMed ID: 27208498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression.
    Williams LM; Debattista C; Duchemin AM; Schatzberg AF; Nemeroff CB
    Transl Psychiatry; 2016 May; 6(5):e799. PubMed ID: 27138798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D.
    Fava M; Alpert JE; Carmin CN; Wisniewski SR; Trivedi MH; Biggs MM; Shores-Wilson K; Morgan D; Schwartz T; Balasubramani GK; Rush AJ
    Psychol Med; 2004 Oct; 34(7):1299-308. PubMed ID: 15697056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.
    Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Slonena EE; Vande Voort JL; Brutsche NE; Zarate CA
    J Clin Psychiatry; 2014 Sep; 75(9):e932-8. PubMed ID: 25295436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study.
    Wu Z; Chen J; Yuan C; Hong W; Peng D; Zhang C; Cao L; Fang Y
    J Affect Disord; 2013 Sep; 150(3):834-9. PubMed ID: 23570952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of anxiety symptoms on improvement of neurocognitive functions in patients with major depressive disorder: A 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study.
    Yoo I; Woo JM; Lee SH; Fava M; Mischoulon D; Papakostas GI; Kim EJ; Chung S; Ha JH; Jeon HJ
    J Affect Disord; 2015 Oct; 185():24-30. PubMed ID: 26142691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial.
    Etkin A; Patenaude B; Song YJ; Usherwood T; Rekshan W; Schatzberg AF; Rush AJ; Williams LM
    Neuropsychopharmacology; 2015 May; 40(6):1332-42. PubMed ID: 25547711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A follow-up study of DSM-III-R generalized anxiety disorder with syndromal and subsyndromal major depression.
    Barbee JG; Billings CK; Bologna NB; Townsend MH
    J Affect Disord; 2003 Feb; 73(3):229-36. PubMed ID: 12547291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials.
    Nelson JC
    Depress Anxiety; 2010; 27(1):12-8. PubMed ID: 20013987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of comorbid anxiety on the effectiveness of Cognitive Therapy and Interpersonal Psychotherapy for Major Depressive Disorder.
    van Bronswijk SC; Lemmens LHJM; Huibers MJH; Arntz A; Peeters FPML
    J Affect Disord; 2018 May; 232():52-60. PubMed ID: 29477584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis.
    Nelson JC; Delucchi K; Schneider LS
    Int J Geriatr Psychiatry; 2009 May; 24(5):539-44. PubMed ID: 19334041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research on Cognitive Function in Anxious Depression Patients in China.
    Duan Y; Wei J; Geng W; Jiang J; Zhao X; Li T; Jiang Y; Shi L; Cao J; Zhu G; Zhang K; Yu X
    J Affect Disord; 2021 Feb; 280(Pt A):121-126. PubMed ID: 33207284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex- and age-related differences in major depressive disorder with comorbid anxiety treated with fluoxetine.
    Cassano P; Soares CN; Cohen LS; Lyster AK; Fava M
    Arch Womens Ment Health; 2004 Jul; 7(3):167-71. PubMed ID: 15241662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of the DSM-5 anxious distress specifier for major depressive disorder.
    Zimmerman M; Martin J; McGonigal P; Harris L; Kerr S; Balling C; Kiefer R; Stanton K; Dalrymple K
    Depress Anxiety; 2019 Jan; 36(1):31-38. PubMed ID: 30311733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-definition transcranial direct current stimulation (HD-tDCS) in major depressive disorder with anxious distress-a study protocol for a double-blinded randomized sham-controlled trial.
    Zhang D; Zhao B; Sun X; Ding K; Sun J; Tao S
    Trials; 2024 May; 25(1):320. PubMed ID: 38750599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.